Pfizer CEO Drops News About Omicron Variant And Covid Vaccines

Pfizer CEO Drops News About Omicron Variant And Covid Vaccines
SHARE

It’s been just revealed that the CEO of Pfizer had something pretty interesting to say about two covid shots and the Omicron variant.

Just to refresh your memory, the new covid variant called Omicron has been making headlines all over the news for a while now, even though the symptomatology is a mild one.

Not too long ago, we revealed that Deseret.com reported that the latest news from the United Kingdom suggest that a common covid symptom has returned for the omicron variant — brain fog. Check out more details in our previous article. 

Pfizer CEO drops news about a new vaccine targetting Omicron 

CNBC just reported that the Pfizer CEO Albert Bourla on Monday said two doses of the company’s vaccine may not provide strong protection against infection from the Omicron Covid variant.

More than that, it’s been also revealed that the original shots have also lost some of their efficacy at preventing hospitalization.

Source: abcnews.go.com

During an interview at J.P. Morgan’s healthcare conference, he emphasized the importance of a third shot to boost people’s protection against omicron.

“The two doses, they’re not enough for omicron,” Bourla said.

He continued and stated the following:

“The third dose of the current vaccine is providing quite good protection against deaths, and decent protection against hospitalizations.”

He also made sure to explain the fact that this variant of the virus is a more difficult target than previous variants.

“Omicron, which has dozens of mutations, can evade some of the protection provided by Pfizer’s original two shots.”

It’s also important to note what he was saying back in 2021 about the vaccine’s efficiency:

 


Pfizer has been making tons of headlines lately due to various controversies involving the covid 19 vaccines and more issues. 

FDA and Pfizer controversy

There has been a massive scandal involving the fact that the FDA asked for 75 years to produce Pfizer vaccine safety data. Now, it seems that things are changing, and you should check out the latest reports on the issue below.

It’s been just reported that the U.S. Food and Drug Administration (FDA) will have eight months — not the 75 years it requested — to release all documents related to the licensing of Pfizer’s Comirnaty covid vaccine. This is what a federal judge ruled Thursday.

Check out more about the latest news on the novel coronavirus and make sure to take a look at our previous article featuring some mind-blowing covid documents allegedly coming from DARPA that have just been leaked by Project Veritas. 

More sources addressed the documents before Project Veritas so far, but the headlines are flooding the media these days more than ever. 


SHARE
Rada Mateescu

Passionate about subjects from the science and health-related areas, Rada has been blogging for about ten years and at Health Thoroughfare, she's covering the latest news on these niches.

Share this post

Post Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.